PI
HALO icon

PEAK6 Investments’s Halozyme HALO Stock Holding History

PEAK6 Investments’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-266
Closed -$10.9K – 4252
2023
Q2 		$9.6K Buy
+266
New +$9.08K ﹤0.01% 3645
2022
Q3 		– Sell
-266
Closed -$9.6K – 5406
2022
Q2 		$9.6K Buy
+266
New +$11.5K ﹤0.01% 5829
2019
Q4 		– Sell
-912
Closed -$15.8K – 3647
2019
Q3 		$14K Sell
912
-27
-3% -$445 ﹤0.01% 3554
2019
Q2 		$16K Sell
939
-177
-16% -$2.86K ﹤0.01% 3448
2019
Q1 		$18K Sell
1,116
-445
-29% -$7.21K ﹤0.01% 3574
2018
Q4 		$23K Buy
1,561
+571
+58% +$9.11K ﹤0.01% 3759
2018
Q3 		$18K Buy
+990
New +$17.3K ﹤0.01% 3922

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PEAK6 Investments's HALO Position: Q3 2023 in Review

PEAK6 Investments sold out of Halozyme (HALO) in Q3 2023, closing a stake of 266 shares — an estimated $10.9K sold.

PEAK6 Investments first reported a position in HALO in Q3 2018 and held it in 7 quarters. The position peaked at $23K in Q4 2018. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

  • PEAK6 Investments reported no remaining Halozyme position as of Q3 2023 after selling out during the quarter.
  • PEAK6 Investments sold 266 Halozyme shares in Q3 2023, an estimated $10.9K.
  • PEAK6 Investments first reported a position in Halozyme in Q3 2018 and held it in 7 quarters.
  • PEAK6 Investments's Halozyme position peaked at $23K in Q4 2018.
  • 389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.